NEUP · Insider Trading
Neuphoria Therapeutics Inc. Common Stock
Every open-market purchase and sale reported by NEUP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-21 | Peter Miles Winston Davies | Director | A | +8,537 deriv. | — |
| 2026-01-21 | David Ian Wilson | Director | A | +8,537 deriv. | — |
| 2026-01-21 | Alan Fisher | Director | A | +17,073 deriv. | — |
| 2026-01-21 | Jane Ryan | Director | A | +8,537 deriv. | — |
| 2025-10-23 | Lynx1 Capital Management LP | 10%+ Owner | Buy | +1,278,220 | +$6.57M |
| 2025-09-02 | Spyros Papapetropoulos | President and CEO | A | +34,559 deriv. | — |
| 2025-05-19 | Spyros Papapetropoulos | President and CEO | A | +27,000 deriv. | — |
| 2025-04-18 | Spyros Papapetropoulos | President and CEO | A | +270,000 deriv. | — |
| 2025-04-18 | Alan Fisher | Director | A | +13,566 deriv. | — |
| 2025-04-18 | David Ian Wilson | Director | A | +6,783 deriv. | — |
| 2025-04-18 | Jane Ryan | Director | A | +6,783 deriv. | — |
| 2025-04-18 | Peter Miles Winston Davies | Director | A | +6,783 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Lynx1 Capital Management LP | 10%+ Owner | 875,328 | $2.96M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NEUP quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.